4.6 Review

Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

Druggable Allosteric Sites in β-Propeller Lectins

Elena Shanina et al.

Summary: Carbohydrate-binding proteins, specifically lectins, are promising targets in drug discovery for combating antimicrobial resistance, yet non-carbohydrate drug-like inhibitors are still lacking. A druggable pocket in a beta-propeller lectin from Burkholderia ambifaria has been identified as a potential target for allosteric inhibitors. Future drug-discovery efforts focusing on small molecule inhibitors could benefit from targeting allosteric sites in lectins to combat antibiotic-resistant pathogens.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

Article Chemistry, Medicinal

Selective Binding of Small Molecules to Vibrio cholerae DsbA Offers a Starting Point for the Design of Novel Antibacterials

Geqing Wang et al.

Summary: DsbA enzymes play a crucial role in the oxidative folding of proteins in Gram-negative bacteria and have potential as a target for controlling bacterial virulence. This study identified a novel small molecule inhibitor that binds to the hydrophobic groove of VcDsbA with higher selectivity compared to EcDsbA. The crystal structures of VcDsbA and EcDsbA in complex with a known ligand revealed different binding modes and provided insights into ligand binding to these enzymes.

CHEMMEDCHEM (2022)

Article Chemistry, Medicinal

Development of Inhibitors of SAICAR Synthetase (PurC) from Mycobacterium abscessus Using a Fragment-Based Approach

Sitthivut Charoensutthivarakul et al.

Summary: This study identified SAICAR synthetase as a promising target for novel antibiotics against Mycobacterium abscessus. A series of compounds with potent inhibitory activity were developed through fragment library screening and crystallographic screening, providing potential for drug development against Mab.

ACS INFECTIOUS DISEASES (2022)

Review Biochemical Research Methods

Fragment-based screening: A new paradigm for ligand and target discovery

Sinead Knight et al.

Summary: Advancements in fragment-based screening, such as Fully Functionalised Fragments (FFFs) and Covalent Fragment screening, present a new paradigm for ligand and target discovery. FFFs offer advantages in accessing diverse chemical space with a small compound library, easy screen optimization, and built-in proteomics tools for target deconvolution in cells. Covalent fragments enable exploration of novel druggable nodes through irreversible fragment interactions. Both FFFs and Covalent fragments provide an additional and complementary approach for disease-centric target identification.

SLAS DISCOVERY (2022)

Article Chemistry, Medicinal

Covalent inhibitors of bacterial peptidoglycan biosynthesis enzyme MurA with chloroacetamide warhead

Katarina Grabrijan et al.

Summary: The study focused on the development of new antibacterial agents by inhibiting the enzyme MurA. A potent compound with potential antibacterial activity was identified, providing a valuable starting point for the development of new antibiotics.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Review Biochemistry & Molecular Biology

Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis

Sheikh Mohammed Arif et al.

Summary: Cystic fibrosis is a progressive genetic disease that predisposes the lungs and other organs to long-lasting microbial infections. Pseudomonas aeruginosa is the most prevalent and deadly pathogen among these microbes. Due to the emergence of drug-resistant strains, there is an urgent need for new antibacterials to treat P. aeruginosa infections. Structure-guided fragment-based drug discovery is a powerful approach in drug development, but it has not been widely used in the development of anti-pseudomonal molecules.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Article Chemistry, Medicinal

A fragment-based drug discovery strategy applied to the identification of NDM-1 β-lactamase inhibitors

Jeremy Caburet et al.

Summary: Hydrolysis of beta-lactam drugs by serine or metallo-beta-lactamases is a major mechanism of antibiotic resistance. New Delhi Metallo-beta-lactamase-1 (NDM-1) is an important target for the development of NDM-1 inhibitors. Using a combination of virtual screening and NMR screening, we identified 37 fragments and synthesized inhibitors with inhibitory activity on NDM-1.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Review Biochemistry & Molecular Biology

Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges

Namdev S. Togre et al.

Summary: The emergence of drug-resistant mycobacteria is a global threat that requires the development of new potent anti-mycobacterial drugs. Fragment-based drug discovery (FBDD) has been recognized as a popular approach to identify potent fragment molecules using virtual, computational, and biophysical methods. FBDD overcomes the limitations of traditional methods and is important for combating NTM and Mtb infections.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Fragment-Based Phenotypic Lead Discovery To Identify New Drug Seeds That Target Infectious Diseases

Yann Ayotte et al.

Summary: Fragment-based lead discovery has been proven to be a powerful technique for identifying starting chemical matter to target specific proteins or nucleic acids. The study successfully applied phenotype cell-based screens using a curated fragment library to identify inhibitors against a range of pathogens, showing that fragment-based phenotypic lead discovery is a promising complementary approach for tackling infectious diseases and other drug-discovery programs.

ACS CHEMICAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Elaboration of a benzofuran scaffold and evaluation of binding affinity and inhibition of Escherichia coli DsbA: A fragment-based drug design approach to novel antivirulence compounds

Luke F. Duncan et al.

Summary: This study elucidates the binding mode of benzofuran derivatives to the active site of bacterial DsbA and their inhibitory effect on its activity, providing a basis for the development of novel anti-virulence compounds.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Fragment-based screening and hit-based substructure search: Rapid discovery of 8-hydroxyquinoline-7-carboxylic acid as a low-cytotoxic, nanomolar metallo β-lactamase inhibitor

Woo Shik Shin et al.

Summary: Metallo-beta-lactamases (MBLs) are zinc-containing carbapenemases that can deactivate a wide range of beta-lactam antibiotics. 8-Hydroxyquinoline-7-carboxylic acid has been identified as a potential low-cytotoxic inhibitor that can restore beta-lactam activity against bacteria expressing VIM-2. Molecule modeling suggests that this compound binds within the dinuclear zinc active site, making it a promising lead candidate for further development.

CHEMICAL BIOLOGY & DRUG DESIGN (2021)

Review Microbiology

QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics

Olga Lomovskaya et al.

Summary: QPX7728 is an ultra-broad-spectrum beta-lactamase inhibitor with potent inhibition against a wide range of clinically important beta-lactamases. It is minimally affected by common resistance mechanisms and shows broad coverage when combined with various beta-lactam antibiotics. The oral delivery option of QPX7728 also provides potential for application in combination products.

FRONTIERS IN MICROBIOLOGY (2021)

Review Biochemistry & Molecular Biology

Fragment-based drug discovery: opportunities for organic synthesis

Jeffrey D. St Denis et al.

Summary: This review discusses the growing demand for organic synthesis in facilitating fragment-based drug discovery, particularly focusing on polar unprotected fragments. It highlights the challenge of synthesis that slows down drug discovery process, and some fragments cannot be further optimized due to synthetic difficulties.

RSC MEDICINAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Fragment-based covalent ligand discovery

Wenchao Lu et al.

Summary: Targeted covalent inhibitors have become a focus in drug discovery, with chemoproteomic strategies and fragment-based drug discovery leading to the identification of new drugs and protein targets. This approach enables high-throughput discovery of potential protein targets and allows for targeting of various amino acids using new chemical technologies.

RSC CHEMICAL BIOLOGY (2021)

Article Chemistry, Medicinal

Discovery of novel tRNA-amino acid dual-site inhibitors against threonyl-tRNA synthetase by fragment-based target hopping

Junsong Guo et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

A novel potent metal-binding NDM-1 inhibitor was identified by fragment virtual, SPR and NMR screening

Huifang Guo et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases

Scott J. Hecker et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Editorial Material Biochemical Research Methods

Functional Genomics for Target Identification

Davide Gianni et al.

SLAS DISCOVERY (2020)

Article Biochemistry & Molecular Biology

Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification

Sherine E. Thomas et al.

NUCLEIC ACIDS RESEARCH (2020)

Article Chemistry, Medicinal

Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity

Yousuke Yamada et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Chemistry, Multidisciplinary

Targeting Metalloenzymes for Therapeutic Intervention

Allie Y. Chen et al.

CHEMICAL REVIEWS (2019)

Article Chemistry, Medicinal

Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety

Frederick Cohen et al.

CHEMMEDCHEM (2019)

Article Biochemistry & Molecular Biology

Targeted 8-hydroxyquinoline fragment based small molecule drug discovery against neglected botulinum neurotoxin type F

Ritika Chauhan et al.

BIOORGANIC CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

The Fragment-Based Development of a Benzofuran Hit as a New Class of Escherichia coli DsbA Inhibitors

Luke F. Duncan et al.

MOLECULES (2019)

Review Biochemistry & Molecular Biology

Concepts and Core Principles of Fragment-Based Drug Design

Philine Kirsch et al.

MOLECULES (2019)

Article Chemistry, Multidisciplinary

Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs

Yujia Wang et al.

NATURE CHEMISTRY (2019)

Review Biochemistry & Molecular Biology

Lectin antagonists in infection, immunity, and inflammation

Joscha Meiers et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2019)

Review Chemistry, Medicinal

Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design

Pasquale Linciano et al.

ACS INFECTIOUS DISEASES (2019)

Article Chemistry, Medicinal

Probing the Interaction of Aspergillomarasmine A with Metallo-beta-lactamases NDM-1, VIM-2, and IMP-7

Alexander Bergstrom et al.

ACS INFECTIOUS DISEASES (2018)

Article Chemistry, Medicinal

Fragment-Based Phenotypic Lead Discovery: Cell-Based Assay to Target Leishmaniasis

Yann Ayotte et al.

CHEMMEDCHEM (2018)

Article Chemistry, Medicinal

Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria

Robert J. Moreau et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors

Ricky Cain et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Biochemistry & Molecular Biology

Drugging tRNA aminoacylation

Joanne M. Ho et al.

RNA BIOLOGY (2018)

Review Biochemical Research Methods

Using Fragment-Based Approaches to Discover New Antibiotics

Bas Lamoree et al.

SLAS DISCOVERY (2018)

Article Chemistry, Multidisciplinary

Application of fragment based virtual screening towards inhibition of bacterial N-acetyglucosaminidase$

T. Tibaut et al.

SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2018)

Article Chemistry, Medicinal

Heterocyclic electrophiles as new MurA inhibitors

Aaron Keeley et al.

ARCHIV DER PHARMAZIE (2018)

Article Microbiology

Whole-Cell Screen of Fragment Library Identifies Gut Microbiota Metabolite Indole Propionic Acid as Antitubercular

Dereje A. Negatu et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Article Infectious Diseases

Fragment-Based Discovery of Inhibitors of the Bacterial DnaG-SSB Interaction

Zorik Chilingaryan et al.

ANTIBIOTICS-BASEL (2018)

Review Biochemistry & Molecular Biology

Current perspectives in fragment-based lead discovery (FBLD)

Bas Lamoree et al.

STRUCTURE-BASED DRUG DESIGN: INSIGHTS FROM ACADEMIA AND INDUSTRY (2017)

Article Chemistry, Medicinal

LpxC inhibitors: a patent review (2010-2016)

Dmitrii V. Kalinin et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2017)

Article Multidisciplinary Sciences

Predictive compound accumulation rules yield a broad - spectrum antibiotic

Michelle F. Richter et al.

NATURE (2017)

Article Biochemistry & Molecular Biology

2-Chloropropionamide As a Low-Reactivity Electrophile for Irreversible Small-Molecule Probe Identification

Dharmaraja Allimuthu et al.

ACS CHEMICAL BIOLOGY (2017)

Article Biochemistry & Molecular Biology

Mechanism of inhibition of botulinum neurotoxin type A light chain by two quinolinol compounds

Yacoba V. T. Minnow et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2017)

Review Pharmacology & Pharmacy

Targeting tuberculosis using structure-guided fragment-based drug design

Vitor Mendes et al.

DRUG DISCOVERY TODAY (2017)

Review Biochemistry & Molecular Biology

Trm5 and TrmD: Two Enzymes from Distinct Origins Catalyze the Identical tRNA Modification, m1G37

Sakurako Goto-Ito et al.

BIOMOLECULES (2017)

Article Biochemistry & Molecular Biology

Ligand and Target Discovery by Fragment-Based Screening in Human Cells

Christopher G. Parker et al.

Article Biochemical Research Methods

Substrate independent ATPase activity may complicate high throughput screening

Micheal L. Tuntland et al.

ANALYTICAL BIOCHEMISTRY (2016)

Article Biochemistry & Molecular Biology

Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure-activity relationship and a pharmacophore model

Gyanendra Kumar et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2016)

Article Biochemistry & Molecular Biology

Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity

Yuchen Zhou et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2016)

Article Medicine, Research & Experimental

Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC

Alice L. Erwin

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)

Article Biochemistry & Molecular Biology

Catalytic pathway, substrate binding and stability in SAICAR synthetase: A structure and molecular dynamics study

Kavyashree Manjunath et al.

JOURNAL OF STRUCTURAL BIOLOGY (2015)

Article Multidisciplinary Sciences

Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds

Magdalena Makowska-Grzyska et al.

PLOS ONE (2015)

Article Multidisciplinary Sciences

Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum

Keith H. Turner et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Multidisciplinary Sciences

Structural basis for full-spectrum inhibition of translational functions on a tRNA synthetase

Pengfei Fang et al.

NATURE COMMUNICATIONS (2015)

Article Chemistry, Multidisciplinary

Application of Fragment-Based Screening to the Design of Inhibitors of Escherichia coli DsbA

Luke A. Adams et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)

Article Chemistry, Medicinal

Identification of Clinically Viable Quinolinol Inhibitors of Botulinum Neurotoxin A Light Chain

Dejan Caglic et al.

JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Multidisciplinary Sciences

Chasing acyl carrier protein through a catalytic cycle of lipid A production

Ali Masoudi et al.

NATURE (2014)

Article Multidisciplinary Sciences

Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance

Andrew M. King et al.

NATURE (2014)

Review Biotechnology & Applied Microbiology

Is there new hope for therapeutic matrix metalloproteinase inhibition?

Roosmarijn E. Vandenbroucke et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

Article Biochemical Research Methods

Structures of SAICAR synthetase (PurC) from Streptococcus pneumoniae with ADP, Mg2+, AIR and Asp

Nina M. Wolf et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2014)

Article Chemistry, Multidisciplinary

Design and Evaluation of the Performance of an NMR Screening Fragment Library

Bradley C. Doak et al.

AUSTRALIAN JOURNAL OF CHEMISTRY (2013)

Article Chemistry, Medicinal

Optimization of Benzoxazole-Based Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase

Suresh Kumar Gorla et al.

JOURNAL OF MEDICINAL CHEMISTRY (2013)

Article Multidisciplinary Sciences

ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase

Huihao Zhou et al.

NATURE (2013)

Article Microbiology

blaNDM-1 Is a Chimera Likely Constructed in Acinetobacter baumannii

M. A. Toleman et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)

Review Pharmacology & Pharmacy

Architecture and Conservation of the Bacterial DNA Replication Machinery, an Underexploited Drug Target

Andrew Robinson et al.

CURRENT DRUG TARGETS (2012)

Review Chemistry, Medicinal

Aminoacyl-tRNA synthetase inhibitors as antimicrobial agents: a patent review from 2006 till present

Bharat Gadakh et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2012)

Article Biochemistry & Molecular Biology

Fucose-binding Lectin from Opportunistic Pathogen Burkholderia ambifaria Binds to Both Plant and Human Oligosaccharidic Epitopes

Aymeric Audfray et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Biochemistry & Molecular Biology

Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase

Tracy L. Keller et al.

NATURE CHEMICAL BIOLOGY (2012)

Article Biochemistry & Molecular Biology

Purine Salvage Pathway in Mycobacterium tuberculosis

R. G. Ducati et al.

CURRENT MEDICINAL CHEMISTRY (2011)

Review Biochemistry & Molecular Biology

The Antibiotic Potential of Prokaryotic IMP Dehydrogenase Inhibitors

L. Hedstrom et al.

CURRENT MEDICINAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism

HongMin Zhang et al.

FASEB JOURNAL (2011)

Article Microbiology

Identification and Biochemical Characterization of Small-Molecule Inhibitors of Clostridium botulinum Neurotoxin Serotype A

Virginia Roxas-Duncan et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

Article Biochemistry & Molecular Biology

Quinolinol and peptide inhibitors of zinc protease in botulinum neurotoxin A: Effects of zinc ion and peptides on inhibition

Huiguo Lai et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)

Review Chemistry, Multidisciplinary

IMP Dehydrogenase: Structure, Mechanism, and Inhibition

Lizbeth Hedstrom

CHEMICAL REVIEWS (2009)

Article Biochemistry & Molecular Biology

The nature of Staphylococcus aureus MurA and MurZ and approaches for detection of peptidoglycan biosynthesis inhibitors

Katy L. Blake et al.

MOLECULAR MICROBIOLOGY (2009)

Review Biotechnology & Applied Microbiology

From carbohydrate leads to glycomimetic drugs

Beat Ernst et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Article Biochemistry & Molecular Biology

SSB as an Organizer/Mobilizer of Genome Maintenance Complexes

Robert D. Shereda et al.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)

Review Microbiology

Membrane lipid homeostasis in bacteria

Yong-Mei Zhang et al.

NATURE REVIEWS MICROBIOLOGY (2008)

Article Chemistry, Medicinal

Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery

Qingning Shu et al.

MEDICINAL RESEARCH REVIEWS (2008)

Review Biochemistry & Molecular Biology

Evolution of carbohydrate antigens - microbial forces shaping host glycomes?

Joseph R. Bishop et al.

GLYCOBIOLOGY (2007)

Article Biochemistry & Molecular Biology

Octameric structure of the human bifunctional enzyme PAICS in purine biosynthesis

Shu-Xing Li et al.

JOURNAL OF MOLECULAR BIOLOGY (2007)

Article Biochemistry & Molecular Biology

Nucleotide complexes of Escherichia coli phosphoribosylaminoimidazole succinocarboxamide synthetase

Nathaniel D. Ginder et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Medicine, General & Internal

Mechanisms of antimicrobial resistance in bacteria

Fred C. Tenover

AMERICAN JOURNAL OF MEDICINE (2006)

Article Chemistry, Medicinal

ZINC - A free database of commercially available compounds for virtual screening

JJ Irwin et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)

Article Chemistry, Medicinal

Inhibitors of phosphopantetheine adenylyltransferase

LH Zhao et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)

Article Biochemistry & Molecular Biology

Genes required for mycobacterial growth defined by high density mutagenesis

CM Sassetti et al.

MOLECULAR MICROBIOLOGY (2003)

Review Microbiology

Why are bacteria refractory to antimicrobials?

D Hogan et al.

CURRENT OPINION IN MICROBIOLOGY (2002)

Article Biochemistry & Molecular Biology

Complete reconstitution of the human coenzyme A biosynthetic pathway via comparative genomics

M Daugherty et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Biochemistry & Molecular Biology

A genome-wide strategy for the identification of essential genes in Staphylococcus aureus

RA Forsyth et al.

MOLECULAR MICROBIOLOGY (2002)

Review Microbiology

Aminoacyl-tRNA synthetases, the genetic code, and the evolutionary process

CR Woese et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2000)